Provided by Tiger Trade Technology Pte. Ltd.

Cohen & Steers

77.23
-0.2600-0.34%
Post-market: 77.230.00000.00%16:59 EDT
Volume:286.34K
Turnover:22.20M
Market Cap:3.97B
PE:23.76
High:78.64
Open:77.64
Low:76.83
Close:77.49
52wk High:86.56
52wk Low:58.39
Shares:51.39M
Float Shares:27.75M
Volume Ratio:1.23
T/O Rate:1.03%
Dividend:2.58
Dividend Rate:3.34%
EPS(TTM):3.25
EPS(LYR):2.97
ROE:27.33%
ROA:14.54%
PB:6.73
PE(LYR):26.00

Loading ...

Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026

GlobeNewswire
·
Jul 13

Solvonis Wins U.S. Research Coverage as AUD Pipeline Targets Large CNS Market

TIPRANKS
·
Jul 13

Insilico Medicine Deepens CNS Drug Development Tie-Up With China Medical System

TIPRANKS
·
Jul 13

Cohen & Steers Crosses CAREIT Threshold, LC Capital Adds to PC Partner

sgx.com
·
Jul 13

Cohen & Steers is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 11

Cohen & Steers price target raised to $84 from $82 at Evercore ISI

TIPRANKS
·
Jul 10

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswire
·
Jul 10

Cohen & Steers Assets Under Management Rise to $100.1 Billion at End-june 2026

Reuters
·
Jul 10

Cohen & Steers - Reports Preliminary Aum of $100.1 Bln as of June 30, 2026

THOMSON REUTERS
·
Jul 10

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for June 2026

THOMSON REUTERS
·
Jul 10

Earning Preview: Cohen & Steers Q2 revenue is expected to increase by 7.08%, and institutional views are cautiously optimistic

Earnings Agent
·
Jul 10

Press Release: Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of Fp-001 42 Mg for Central Precocious Puberty

Dow Jones
·
Jul 09

LG CNS Set to Benefit from Parent Group's Physical AI Investments

Dow Jones
·
Jul 09

Cohen & Steers Updates Financial Calendar with Upcoming Q2 Results Release and Conference Call

Reuters
·
Jul 09

Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

GlobeNewswire
·
Jul 07

Cohen & Steers emerges as substantial shareholder of Centurion Accommodation REIT

Teo Zheng Long
·
Jul 03

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 03

CNS Pharmaceuticals Announces Strategic Oncology-Neurology Realignment

TIPRANKS
·
Jul 02

Press Release: Oryzon Raises EUR12 Million and Signs a Financing Agreement with Cofides to Strengthen Its Balance Sheet and Accelerate Its Clinical Programs

Dow Jones
·
Jul 01

Swiss Hospital Landlord Infracore Targets $1 Billion Valuation in IPO

Dow Jones
·
Jun 30